University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "de Bono, J"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 9.

Article

Ang, JE, Pal, A, Asad, YJ, Henley, AT, Valenti, M, Box, G, de haven Brandon, A, Revell, Victoria, Skene, Debra, Venturi, M, Rueger, R, Meresse, V, Eccles, SA, de Bono, JS, Kaye, SB, Workman, P, Banerji, U and Raynaud, FI (2017) Modulation of plasma metabolite biomarkers of MAPK pathway with the MEK inhibitor RO4987655: pharmacodynamic and predictive potential in metastatic melanoma. Molecular Cancer Therapeutics.

Roulstone, V, Khan, K, Pandha, HS, Rudman, S, Coffey, M, Gill, GM, Melcher, AA, Vile, R, Harrington, KJ, de Bono, J and Spicer, J (2015) Phase I Trial of Cyclophosphamide as an Immune Modulator for Optimizing Oncolytic Reovirus Delivery to Solid Tumors CLINICAL CANCER RESEARCH, 21 (6). pp. 1305-1312.

de Bono, JS, Piulats, JM, Pandha, HS, Petrylak, DP, Saad, F, Aparicio, LMA, Sandhu, SK, Fong, P, Gillessen, S, Hudes, GR, Wang, T, Scranton, J and Pollak, MN (2014) Phase II Randomized Study of Figitumumab plus Docetaxel and Docetaxel Alone with Crossover for Metastatic Castration-Resistant Prostate Cancer CLINICAL CANCER RESEARCH, 20 (7). pp. 1925-1934.

Richards, J, Lim, AC, Hay, CW, Taylor, AE, Wingate, A, Nowakowska, K, Pezaro, C, Carreira, S, Goodall, J, Arlt, W, McEwan, IJ, de Bono, JS and Attard, G (2012) Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100 CANCER RESEARCH, 72 (9). pp. 2176-2182.

Attard, G, Richards, J and de Bono, JS (2011) New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway CLINICAL CANCER RESEARCH, 17 (7). pp. 1649-1657.

Yap, TA, Brunetto, A, Pandha, H, Harrington, K and de Bono, JS (2008) Reovirus therapy in cancer: has the orphan virus found a home? EXPERT OPINION ON INVESTIGATIONAL DRUGS, 17 (12). pp. 1925-1935.

Errington, F, Steele, L, Prestwich, R, Harrington, KJ, Pandha, HS, Vidal, L, de Bono, J, Selby, P, Coffey, M, Vile, R and Melcher, A (2008) Reovirus activates human dendritic cells to promote innate antitumor immunity JOURNAL OF IMMUNOLOGY, 180 (9). pp. 6018-6026.

Qiao, J, Wang, H, Kottke, T, White, C, Twigger, K, Diaz, RM, Thompson, J, Selby, P, de Bono, J, Melcher, A, Pandha, H, Coffey, M, Vile, R and Harrington, K (2008) Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus CLINICAL CANCER RESEARCH, 14 (1). pp. 259-269.

Conference or Workshop Item

Karapanagiotou, E, Pandha, HS, Hall, G, Chester, J, Melcher, A, Coffey, M, de Bono, J, Gore, ME, Nutting, CM and Harrington, KJ (2009) Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers In: 45th Annual Meeting of the American-Society-of-Clinical-Oncology, 2009-05-29 - 2009-06-02, Orlando, FL.

This list was generated on Fri Sep 22 04:52:24 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800